Clinical studies recruiting near Augusta

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Observational Study Protocol: LIVER-R
Phase N/A · Research Site · AstraZeneca · NCT06252753 Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Phase 3 · Joseph Broderick, MD · NCT07227246 Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
Phase 3 · Princess Maxima Center for Pediatric Oncology · NCT05327894 MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi
Phase 2 · Augusta University Medical Center · National Cancer Institute (NCI) · NCT05564390 Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
Phase N/A · Galderma R&D · NCT06988605 Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients
Phase 2 · Miltenyi Biomedicine GmbH · NCT04844866 Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · Augusta University Medical Center · NRG Oncology · NCT05624996 Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in Advanced Ovarian Cancer
Phase 3 · AGO Study Group · NCT05009082 A Non-interventional, Prospective Study With Benralizumab
Phase N/A · AstraZeneca · NCT06422078 REscue Stenting With CREDO® Heal for Recanalisation After Unsuccessful Thrombectomy (RECHRUT)
Phase N/A · Acandis GmbH · NCT05345483 Effects of Home Base Whole-body Vibration in Osteoarthritis. (VIBE-Rx2)
NA · Augusta University/Georgia Prevention Institute/ Laboratory · Augusta University · NCT06058169 BREATHE Free: a Pilot Feasibility Trial
NA · Augusta University · Augusta University · NCT06862050 Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Phase 3 · PedAL BCU, LLC · NCT05183035 A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Phase 2/Phase 3 · Augusta University Medical Center · National Cancer Institute (NCI) · NCT05691478 Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
Phase 2 · Augusta University Health · Giselle Sholler · NCT02559778 A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Sympt
Phase 4 · Neurocrine Clinical Site · Neurocrine Biosciences · NCT07105111 A Study on the Tolerability, Safety and Effectiveness of Asciminib in Patients With Philadelphia Chromosome-positive Chr
Phase N/A · Novartis Pharmaceuticals · NCT07549516 Immune Biomarkers in Prostate Cancer Patients Treated With Brachytherapy
Phase N/A · University of Erlangen-Nürnberg Medical School · NCT07131956 Real-World Clinical Experience of Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Olaparib +
Phase N/A · AstraZeneca · NCT06380738 Endometrial Cancer Lymphadenectomy Trial
NA · Philipps University Marburg · NCT03438474 Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
NA · Augusta University Medical Center · Alliance for Clinical Trials in Oncology · NCT07091617 A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With
Phase 2 · Augusta University · Biostar Pharma, Inc. · NCT06764940 A Phase 1/2 Study of BHV-1510 (Previously PBI-410) in Advanced Solid Tumors
Phase 1/Phase 2 · Site-110 · Biohaven Therapeutics Ltd. · NCT06384807 Peripheral Neuropathy in Patients Receiving Enfortumab Vedotin and Pembrolizumab as First Line Treatment for Metastatic
Phase N/A · Comprehensive Cancer Center Munich (CCCM) · NCT06657157 A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy
Phase N/A · Southeast Retina Center, P.C. · Astellas Pharma Global Development, Inc. · NCT06779773 A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic
Phase 3 · AstraZeneca · NCT06868277 A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Phase 2 · Augusta University Medical Center · Children's Oncology Group · NCT04322318 International HIT-MED Registry (I-HIT-MED)
Phase N/A · Universitätsklinikum Hamburg-Eppendorf · NCT02417324 A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants Wit
Phase 3 · Merck Sharp & Dohme LLC · NCT06077760 Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Phase 3 · NRG Oncology · NCT05946213

Look up another city

Look up another condition